In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19.
Saved in:
| Title: | In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19. |
|---|---|
| Authors: | Sachdeva C; Amity Institute of Virology and Immunology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India., Wadhwa A; Department of Chemistry, University of Delhi, North Campus, University Enclave, Delhi, India., Kumari A; Amity Institute of Virology and Immunology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India., Hussain F; Department of Chemistry, University of Delhi, North Campus, University Enclave, Delhi, India., Jha P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Kaushik NK; Amity Institute of Virology and Immunology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India. |
| Source: | Omics : a journal of integrative biology [OMICS] 2020 Oct; Vol. 24 (10), pp. 568-580. Date of Electronic Publication: 2020 Jul 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101131135 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8100 (Electronic) Linking ISSN: 15362310 NLM ISO Abbreviation: OMICS Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1557-8100 |
|---|---|
| DOI: | 10.1089/omi.2020.0071 |
